Three Undervalued Small Caps In United Kingdom With Insider Buying

LSE:DOM Share price vs Value as at Oct 2024

Simply Wall St Value Rating: ★★★★☆☆

Overview: Oxford Instruments is a company specializing in the development and manufacturing of high-technology tools and systems for research, discovery, service, healthcare, materials analysis, and characterization with a market cap of approximately £1.75 billion.

Operations: Oxford Instruments generates revenue primarily from three segments: Materials & Characterisation (£252.20 million), Research & Discovery (£142.10 million), and Service & Healthcare (£76.10 million). The company has seen fluctuations in its net income margin, which peaked at 13.22% in September 2023, reflecting varying profitability over time. Operating expenses are a significant cost component, with sales and marketing being the largest expense within this category.

PE: 24.2x

Oxford Instruments, a key player in the UK’s small stock sector, has caught attention with insider confidence demonstrated through recent share purchases. Their strategic presentations at various global conferences, including the NanoFabUK Symposium and Faraday Institution Conference, highlight their active industry engagement. Despite relying solely on external borrowing for funding, which poses higher risk compared to customer deposits, earnings are projected to grow 10% annually. This growth potential suggests promising future prospects for investors seeking value opportunities.

LSE:OXIG Share price vs Value as at Oct 2024

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Videndum is a company specializing in providing media, creative, and production solutions with a market cap of £0.37 billion.

Operations: Videndum generates revenue primarily from Media Solutions (£144.70 million), Creative Solutions (£54.90 million), and Production Solutions (£98 million). The company’s net income margin has shown variability, with recent figures indicating a decline to -8.74% as of October 2024. Operating expenses include significant allocations to sales and marketing, R&D, and general & administrative costs, impacting overall profitability.

PE: -10.2x

Videndum, a UK-based company with a small capitalization, has recently faced challenges including being dropped from the S&P Global BMI Index on September 10, 2024. Despite reporting a net loss of £12.8 million for H1 2024 compared to £46.5 million the previous year, insider confidence remains evident through significant share purchases over recent months. While its funding primarily relies on external borrowing, Videndum’s earnings are projected to grow significantly at an annual rate of 113%, suggesting potential future value amidst current volatility and past shareholder dilution.

LSE:VID Share price vs Value as at Oct 2024

Embark on your investment journey to our 27 Undervalued UK Small Caps With Insider Buying selection here.

Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St’s portfolio, where intuitive tools await to help optimize your investment outcomes.

Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include LSE:DOM LSE:OXIG and LSE:VID.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com